Article
Development of anaphylactic shock in haemophilia B patients with inhibitors.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis - 1 Mar 1998
Warrier I, Lusher J M
Abstract excerpt
The development of inhibitor antibody is a serious complication of haemophilia in young children. The incidence of factor IX (FIX) inhibitors in haemophilia B patients is five- to 10-times less common (1.5-3%) than the incidence of FVIII inhibitors in haemophilia A (15-30%). Inhibitors are commonly associated with the total absence of FIX antigen due to total deletions or other major derangements of the FIX gene....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.